News & Updates
Filter by Specialty:
Progestin shows therapeutic potential in PR-positive endometrial cancer
Progestin therapy appears to yield high response rates in advanced stage and recurrent endometrial cancer that is positive for progesterone receptor (PR) expression, while having low toxicity, according to a study.
Progestin shows therapeutic potential in PR-positive endometrial cancer
08 Dec 2022
Coffee intake lowers risk of endometrial cancer
Women who love to drink coffee will have more reason to do so following a study that reports an association between coffee consumption and a reduced risk of endometrial cancer, particularly among those with higher body mass index (BMI).
Coffee intake lowers risk of endometrial cancer
23 Nov 2022
Laparoscopic better than abdominal radical hysterectomy for cervical cancer
Laparoscopic radical hysterectomy (LRH) leads to more positive outcomes than abdominal radical hysterectomy (ARH) in the treatment of cervical cancer, reveals a study.
Laparoscopic better than abdominal radical hysterectomy for cervical cancer
21 Nov 2022
Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids
Treatment with relugolix combination for up to 52 weeks yields sustained reductions in heavy menstrual bleeding as well as subsequent increases in iron stores in women with uterine leiomyomas, as shown in a study.
Long-term relugolix combo helps with heavy periods, anaemia in women with uterine fibroids
16 Nov 2022
Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes
Pretreatment sarcopenia appears to worsen survival in patients with gynaecologic cancers, such as ovarian (OC), endometrial (EC), and cervical (CC), reports a study. Including this assessment into cancer management may help improve prognosis.